169 related articles for article (PubMed ID: 32258418)
1. The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma.
Chidambaranathan-Reghupaty S; Mendoza R; Fisher PB; Sarkar D
Hepatoma Res; 2018; 4():. PubMed ID: 32258418
[TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional Inhibition of Protein Tyrosine Phosphatase Nonreceptor Type 23 by Staphylococcal Nuclease and Tudor Domain Containing 1: Implications for Hepatocellular Carcinoma.
Jariwala N; Mendoza RG; Garcia D; Lai Z; Subler MA; Windle JJ; Mukhopadhyay ND; Fisher PB; Chen Y; Sarkar D
Hepatol Commun; 2019 Sep; 3(9):1258-1270. PubMed ID: 31497746
[TBL] [Abstract][Full Text] [Related]
3. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma.
Wright T; Wang Y; Stratton SA; Sebastian M; Liu B; Johnson DG; Bedford MT
Biochem J; 2023 Nov; 480(22):1805-1816. PubMed ID: 37905668
[TBL] [Abstract][Full Text] [Related]
4. Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).
Jariwala N; Rajasekaran D; Srivastava J; Gredler R; Akiel MA; Robertson CL; Emdad L; Fisher PB; Sarkar D
Int J Oncol; 2015 Feb; 46(2):465-73. PubMed ID: 25405367
[TBL] [Abstract][Full Text] [Related]
5. Insights Into
Ochoa B; Chico Y; Martínez MJ
Front Oncol; 2018; 8():606. PubMed ID: 30619748
[TBL] [Abstract][Full Text] [Related]
6. The Role of the PRMT5-SND1 Axis in Hepatocellular Carcinoma.
Wright T; Wang Y; Bedford MT
Epigenomes; 2021 Mar; 5(1):. PubMed ID: 33768972
[TBL] [Abstract][Full Text] [Related]
7. SREBP-2-driven transcriptional activation of human SND1 oncogene.
Armengol S; Arretxe E; Enzunza L; Llorente I; Mendibil U; Navarro-Imaz H; Ochoa B; Chico Y; Martínez MJ
Oncotarget; 2017 Dec; 8(64):108181-108194. PubMed ID: 29296233
[TBL] [Abstract][Full Text] [Related]
8. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
9. SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma.
Cui X; Zhao C; Yao X; Qian B; Su C; Ren Y; Yao Z; Gao X; Yang J
RNA Biol; 2018; 15(10):1364-1375. PubMed ID: 30321081
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling.
Santhekadur PK; Akiel M; Emdad L; Gredler R; Srivastava J; Rajasekaran D; Robertson CL; Mukhopadhyay ND; Fisher PB; Sarkar D
FEBS Open Bio; 2014; 4():353-61. PubMed ID: 24918049
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular insights into the role of SND1 in lipid metabolism.
Navarro-Imaz H; Ochoa B; García-Arcos I; Martínez MJ; Chico Y; Fresnedo O; Rueda Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158589. PubMed ID: 31978555
[TBL] [Abstract][Full Text] [Related]
12. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.
Yoo BK; Santhekadur PK; Gredler R; Chen D; Emdad L; Bhutia S; Pannell L; Fisher PB; Sarkar D
Hepatology; 2011 May; 53(5):1538-48. PubMed ID: 21520169
[TBL] [Abstract][Full Text] [Related]
13. Profiling of promoter occupancy by the SND1 transcriptional coactivator identifies downstream glycerolipid metabolic genes involved in TNFα response in human hepatoma cells.
Arretxe E; Armengol S; Mula S; Chico Y; Ochoa B; Martínez MJ
Nucleic Acids Res; 2015 Dec; 43(22):10673-88. PubMed ID: 26323317
[TBL] [Abstract][Full Text] [Related]
14. MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
Ma F; Song H; Guo B; Zhang Y; Zheng Y; Lin C; Wu Y; Guan G; Sha R; Zhou Q; Wang D; Zhou X; Li J; Qiu X
Oncotarget; 2015 Jul; 6(19):17404-16. PubMed ID: 25965817
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrion-Localized SND1 Promotes Mitophagy and Liver Cancer Progression Through PGAM5.
Liang S; Zhu C; Suo C; Wei H; Yu Y; Gu X; Chen L; Yuan M; Shen S; Li S; Sun L; Gao P
Front Oncol; 2022; 12():857968. PubMed ID: 35433434
[TBL] [Abstract][Full Text] [Related]
16. SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis.
Yu L; Di Y; Xin L; Ren Y; Liu X; Sun X; Zhang W; Yao Z; Yang J
Oncogene; 2017 Jul; 36(27):3903-3914. PubMed ID: 28263968
[TBL] [Abstract][Full Text] [Related]
17. SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells.
Xin L; Zhao R; Lei J; Song J; Yu L; Gao R; Ha C; Ren Y; Liu X; Liu Y; Yao Z; Yang J
FASEB J; 2019 Mar; 33(3):3795-3806. PubMed ID: 30509125
[TBL] [Abstract][Full Text] [Related]
18. The promoter of cell growth- and RNA protection-associated SND1 gene is activated by endoplasmic reticulum stress in human hepatoma cells.
Armengol S; Arretxe E; Enzunza L; Mula S; Ochoa B; Chico Y; Martínez MJ
BMC Biochem; 2014 Dec; 15():25. PubMed ID: 25494629
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors.
Cui X; Zhang X; Liu M; Zhao C; Zhang N; Ren Y; Su C; Zhang W; Sun X; He J; Gao X; Yang J
Genomics; 2020 Nov; 112(6):3958-3967. PubMed ID: 32645525
[TBL] [Abstract][Full Text] [Related]
20. NF-κB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene.
Armengol S; Arretxe E; Rodríguez L; Ochoa B; Chico Y; Martínez MJ
Biochimie; 2013 Apr; 95(4):735-42. PubMed ID: 23160072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
